FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereafter FRONTEO) has announced the medical treatise search AI "Amanogawa ver. 1.4".

 

　AmanogawaIs a treatise search AI system equipped with FRONTEO's original AI engine "Concept Encoder (trademark: concept encoder, reading: concept encoder)".When the user inputs a sentence such as a word or hypothesis of interest, AI instantly detects and analyzes related papers from a large number of papers published in PubMed *, and plots them on the main screen "Space Map". increase.Individual papers are indicated by dots, and the degree of similarity of contents is shown by color and positional relationship, and the whole picture can be grasped at a glance. By using Concept Encoder, not only papers containing search terms but also search terms are included. A major feature is that it is possible to perform a "vector search" to detect treatises that use synonyms and that have similar contents and concepts.

 

　In addition, "Word Cloud" that visually presents the contents included in the search result categories, "Mesh Term" that shows the contents of each category and "Terms Frequency" that shows the frequency of appearance, and the yearly transition of the contents show the trend of treatises. Various functions such as "Chronological Chart" that can be grasped and "Card Box" that displays a list of the top 100 articles that are highly related to search terms and texts support a significant improvement in the efficiency of article search.

 

　Up until now, Amanogawa has been able to filter the search results in three ways: full results display, keyword search result display, vector search result display, and hybrid display of keywords and vector search results.With this version upgrade, a new "discovery search display" that displays only vector search results has been added, making it possible to clearly check article information that cannot be found without using Amanogawa.It is expected that this will lead to further efficiency and expansion of research activities and innovative discoveries.

 

 

An example of search result display.In addition to displaying all results (upper), keywords, vectors,
Convenience of information search is improved by switching between hybrid and discovery.

 

　Through the development of AI systems, FRONTEO will continue to contribute to improving the efficiency of medical and pharmaceutical research, promoting DX (digital transformation), and improving the quality of medical care and the QOL of patients.

 

* A database of biomedical treatises created by the National Center for Biological Sciences in the National Library of Medicine.

 

■ About Concept Encoder
URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals, and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

■ About FRONTEO　URL:https://www.fronteo.com/
FRONTEO means from a huge amount of text data using the in-house developed AI engine "KIBIT" specializing in natural language processing, "Concept Encoder (trademark: conceptencoder, reading: concept encoder)", and "Looca Cross". It is a data analysis company that extracts important information and supports the business of the company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support corporate international litigation. Has been deployed.Based on the AI ​​technology cultivated in this business, we will expand the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge", We contribute to solving various corporate issues such as drug discovery support, dementia diagnosis support, finance, personnel, and sales support. Listed on TSE Mothers (currently TSE Growth) on June 2014, 2007. Obtained a first-class medical device manufacturing and sales business license in January 6 (permit number: 26B2021X1), and notified the managed medical device sales business in September of the same year (notification number: 13 Minato Misei Equipment No. 1).The capital is 10350 thousand yen (as of March 9, 3).

* FRONTEO, Amanogawa, conceptencoder, KIBIT, and Looca Cross are registered trademarks of FRONTEO in Japan.